Related references
Note: Only part of the references are listed.Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients
I. Wertel et al.
TUMOR BIOLOGY (2015)
Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP
Eyad Elkord et al.
ONCOTARGET (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer
S. T. Ward et al.
BRITISH JOURNAL OF CANCER (2015)
LPS Modulates Rhinovirus-Induced Chemokine Secretion in Monocytes and Macrophages
Maya R. Karta et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Emerging roles of regulatory T cells in tumour progression and metastasis
Elizabeth C. Halvorsen et al.
CANCER AND METASTASIS REVIEWS (2014)
Macrophages Are More Potent Immune Suppressors Ex Vivo Than Immature Myeloid-Derived Suppressor Cells Induced by Metastatic Murine Mammary Carcinomas
Melisa J. Hamilton et al.
JOURNAL OF IMMUNOLOGY (2014)
Ensembl Genomes 2013: scaling up access to genome-wide data
Paul Julian Kersey et al.
NUCLEIC ACIDS RESEARCH (2014)
FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast
Aseem Lal et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
Psoriasis patients exhibit impairment of the high potency CCR5+ T regulatory cell subset
David C. Soler et al.
CLINICAL IMMUNOLOGY (2013)
Association of chemotactic factor receptor 5 gene with breast cancer
Y. Zhang et al.
GENETICS AND MOLECULAR RESEARCH (2013)
Dynamics of T-cell infiltration during the course of ovarian cancer: The gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells
Anna Fialova et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model
Laura Ochoa-Callejero et al.
PLOS ONE (2013)
The CCL5/CCR5 axis promotes metastasis in basal breast cancer
Marco Velasco-Velazquez et al.
ONCOIMMUNOLOGY (2013)
FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis
Miki Takenaka et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Basis of CTLA-4 function in regulatory and conventional CD4+ T cells
Xuguang Tai et al.
BLOOD (2012)
Tumor-Derived Chemokine CCL5 Enhances TGF-β-Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
Li-Yuan Chang et al.
CANCER RESEARCH (2012)
CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
Marco Velasco-Velazquez et al.
CANCER RESEARCH (2012)
The Indispensable Role of CCR5 for In Vivo Suppressor Function of Tumor-Derived CD103+ Effector/Memory Regulatory T Cells
Li-Yuan Chang et al.
JOURNAL OF IMMUNOLOGY (2012)
Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth
Eva Schlecker et al.
JOURNAL OF IMMUNOLOGY (2012)
Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells
Hiroyuki Tao et al.
LUNG CANCER (2012)
CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
Fangfang Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Targeting Regulatory T Cells in Cancer
William L. Byrne et al.
CANCER RESEARCH (2011)
CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
Elda Righi et al.
CANCER RESEARCH (2011)
An Aberrant Thymus in CCR5-/- Mice Is Coupled with an Enhanced Adaptive Immune Response in Fungal Infection
Danielle N. Kroetz et al.
JOURNAL OF IMMUNOLOGY (2011)
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling
Wei Tan et al.
NATURE (2011)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene et al.
NATURE (2011)
Tumor-Associated Macrophages Recruit CCR6+ Regulatory T Cells and Promote the Development of Colorectal Cancer via Enhancing CCL20 Production in Mice
Jinlin Liu et al.
PLOS ONE (2011)
Two modes of immune suppression by Foxp3+ regulatory T cells under inflammatory or non-inflammatory conditions
Tomoyuki Yamaguchi et al.
SEMINARS IN IMMUNOLOGY (2011)
The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
Je-In Youn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tumor Immune Evasion
Carlene L. Zindl et al.
SCIENCE (2010)
Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome
Michael Gobert et al.
CANCER RESEARCH (2009)
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
Karl S. Peggs et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
Marcus C. B. Tan et al.
JOURNAL OF IMMUNOLOGY (2009)
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Satish L. Deshmane et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
Population pharmacokinetic/pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patients
Maria C. Rosario et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection
Sharon S. Lieberman-Blum et al.
CLINICAL THERAPEUTICS (2008)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy
Justin T. Jordan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Species selectivity of small-molecular antagonists for the CCR5 chemokine receptor
Yuji Saita et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Allosteric effects of antagonists on signalling by the chemokine receptor CCR5
Ben Haworth et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumor-driven evolution of immunosuppressive networks during malignant progression
Ryungsa Kim et al.
CANCER RESEARCH (2006)
Defects in the human leukocyte antigen class I antigen-processing machinery in head and neck squamous cell carcinoma: Association with clinical outcome
M Meissner et al.
CLINICAL CANCER RESEARCH (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: Requirement of CCR5
EA Lynch et al.
JOURNAL OF IMMUNOLOGY (2003)
The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3
P Gao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model
M Parviz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
UK Liyanage et al.
JOURNAL OF IMMUNOLOGY (2002)
Pharmacological characterization of the chemokine receptor, CCR5
A Mueller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice
M Mack et al.
JOURNAL OF IMMUNOLOGY (2001)
Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors
J Blaszczyk et al.
BIOCHEMISTRY (2000)
Share Paper
